|Articles|October 1, 2019
- Pharmaceutical Executive-10-01-2019
- Volume 39
- Issue 10
Pharmaceutical Executive, October 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive October 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
Tech Tour for the C-Suite: Pharma’s Digital Futurealmost 7 years ago
It Starts with a Scribblealmost 7 years ago
Olivier Laureau, Servier: Free to Grow, Innovatealmost 7 years ago
Corey McCann: A PDT Pioneeralmost 7 years ago
Data Shape-Up: Striving to Standardizealmost 7 years ago
Policy Sync-Up: The Drug Importation Conundrumalmost 7 years ago
Validating Value Data: AI and Outcomesalmost 7 years ago
Underlying Platform: Data Unleashedalmost 7 years ago
Surfing the Wave: The Patient-Data Puzzlealmost 7 years ago
Where Does Europe’s Drug Industry Go from Here?Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
2
Jasper Therapeutics to Acquire Kira Pharmaceuticals in $132 Million Merger Agreement
3
Pharmaceutical Executive Daily: FDA Approves Lipfendra
4
From Dr. Google to Dr. Claude: Why the Most Important Patient Support Innovation Is Still Human Connection
5